5th February 2020

Third PROMPPT Stakeholder workshop

On the evening of January 30th 2020, 14 stakeholders from primary care (GPs, practice nurses, practice managers, clinical pharmacists), health psychology, addiction and community pain services, and patient representatives met for a third and final time in the intervention development phase of the PROMPPT programme. In the meeting stakeholders were given an overview of the work that has been completed since their last meeting in September 2019. Dr Sarah Harrisson shared developments of the pain review to be delivered by clinical pharmacists and supporting materials. Dr Nicola Cornwall also provided an update of Q-PROMPPT qualitative study findings taking into account information from the 4 different elements of the study:

  • GP, clinical pharmacist, and patient interviews
  • Clinical pharmacist focus groups
  • Online research forum (Q-PROMPPT Blog)
  • In-practice testing of a prototype pain review

Discussions ensued on key areas for the on-going iterative development of the intervention. We would like to express our gratitude to all our stakeholders and the expertise they have shared for the PROMPPT programme. We hope you have enjoyed being part of the PROMPPT journey and look forward to the next phase of the project.

23rd January 2020

PROMPPT team to present development work at a prestigious research and science conference

This week the research team found out that an abstract with the title, Development of a primary care review for patients prescribed opioid medicines for persistent pain, led by clinical pharmacists, has been accepted for an oral presentation at the PHE Public Health Research and Science Conference 2020, taking place at Manchester University on Tuesday 31 March and Wednesday 1 April. This will be the first opportunity for the team to share some of the findings of the development work undertaken during the first phase of the research programme.

18th December 2019

Q-PROMPPT Blog is now closed

After 11 weeks of being online to participants, the Q-PROMPPT Blog is now closed. The Q-PROMPPT study team would like to thank everyone who participated in the blog. We are very grateful to you for taking the time to share your experiences and views. We are in the process of analysing all the comments posted to help us develop a new way for clinical pharmacists working in GP surgeries to improve the care for people taking regular opioids for long-term pain. We will test how well this works in future studies.

If you would like to keep updated about the PROMPPT research programme and the findings of the Q-PROMPPT research blog, please visit the PROMPPT website where we will post regular updates.

We will also publish results, as they become available on the Keele University Research Institute for Primary Care & Health Sciences website in the new year.

11th December 2019

Q-PROMPPT Blog to close on 18th December

Over the last 10 weeks we have formed an online research community for people living with persistent pain. Many people have joined our community and shared their views and experiences to help improve care for people living with long-term pain. We would like to say a BIG thank you for your participation. Your posts and comments are valuable and will help our research team to better develop a pain review that is acceptable, meaningful, and helpful to people living with long-term pain.

The blog will remain open until 18th December to current and new participants. The Q-PROMPPT Blog will close on the afternoon of 18th December and will no longer be available to participants after this time. Updates on how the Q-PROMPPT blog has impacted the PROMPPT pain review will be published on this website next year.

6th November 2019

Pharmacist training begins with a practice run

Patient and clinical pharmacists were represented at the very first practice run of the PROMPPT pharmacist training package on Friday 1st November. The training was led by Dr Julie Ashworth, Prof Tamar Pincus and collaborators from the Keele University School of Medicine, Dr Janet Lefroy and Dr Matt Webb. The training, once fully developed, will support pharmacists to review patients with persistent pain and regularly taking opioid medicines.

Pharmacist trainees and PROMPPT research team members at the PROMPPT training on 1st November (From left to right, Robert Saunders, Nirlas Bathia, Dr Julie Ashworth, Dr Matt Webb, Dr Janet Lefroy, Mara Cope).

Patient representative, Deb Hickman supporting pharmacist Robert Saunders to have conversations about living with pain and taking opioid medicines.

23rd October 2019

How are pain medication reviews currently done? New discussion topic on the Q-PROMPPT Blog

Four discussion topics are now open on the Q-PROMPPT Blog. Participants of the research blog are discussing their experiences and views of:

  1. Living with long-term pain
  2. Taking medicines for long-term pain
  3. Talking to healthcare professionals about pain
  4. Pain medication reviews – current practice

The Q-PROMPPT Blog is open for the next 7-9 weeks to people with experience of living with long-term pain and using medicines for their pain. People can join the blog at any time whilst it is open.

Find out more here.

8th October 2019

New discussion topic on the Q-PROMPPT Blog

The Q-PROMPPT Blog has launched its second topic: Experiences of taking medication for long-term pain.

The Q-PROMPPT Blog is an online discussion forum for people living with persistent pain to share their views and experiences. Information from the blog will be used to help improve care for people living with long-term pain in the UK.

Find out more here.

7th October 2019

PROMPPT and Q-PROMPPT Blog featured in the Pharmaceutical Journal

The Pharmaceutical Journal published an article about PROMPPT. The piece offers an overview of the 5-year programme and celebrates the launch of the Q-PROMPPT Blog. Read more here.

3rd October 2019

Q-PROMPPT Research Blog is Live

We are excited to announce the Q-PROMPPT Blog is now open.

Do you live with long-term pain? Are you taking (or have taken in the past) opioid medicines for your pain? The PROMPPT team are keen to hear from you. We are interested in your views and experiences to help improve the care people living with pain receive.

To help them learn from as many different people as possible, the research team has set up an online discussion forum called the Q-PROMPPT Blog. You can take part via the internet how and when they want to. The blog is designed so that people with basic computer skills with no experience of using discussion forums can fully participate.

You can find out more about the Q-PROMPPT Blog and how to participate here.

4th September 2019

Dr Julie Ashworth featured on Airing Pain podcast

Dr Julie Ashworth, Senior Lecturer in Pain Medicine and Principal Investigator on the PROMPPT programme, features on this month’s Pain Concern podcast, Airing Pain. The episode focuses on patients as research participants and collaborators. Approximately 13 minutes into the episode you can hear what Julie has to say about PROMPPT and our online research forum for people with persistent pain, the Q-PROMPPT blog. Simply click play on the link below and have a listen.

29th August 2019

PROMPPT Bulletin Launched

We are excited to announce the publication of our PROMPPT bulletin: PROMPPT Update . The bulletin offers a summary of the latest project developments and progress with the research programme. In this first edition, we give an overview of the programme, the PROMPPT community, and highlight an example of how the community has made an impact on the research we’re doing. To open a PDF version of the newsletter click here.

18th July 2019

Q-PROMPPT has the green light to Go, Go, Go!

The PROMPPT team is glad to announce the first phase of the project, called Q-PROMPPT, has been granted ethical approval by the Research Ethics Committee and Health Research Association and given ‘Green Light’ by Keele University Clinical Trials Unit to begin the study. Recruitment has now begun inviting people to participate in Q-PROMPPT interviews. These discussions will help inform improvements to the support people with long-term pain receive in primary care.

Who are we inviting to take part?

Patients – Keele Clinical Trials Network are working with GP practices in the West Midlands area to invite people, who are living with long-term pain and taking regular opioid medicines, to be interviewed by one of our researchers.

GPs and Clinical Pharmacists – if you are a GP or Clinical Pharmacist currently practicing in the West Midlands area and are interested in being interviewed as part of the project you can contact us here.

15th January 2019

£2.4 million grant to help reduce overprescribing of opioids A research team from Keele University’s Institute for Primary Care and Health Sciences has been awarded a major grant of £2.4million from the National Institute for Health Research (NIHR) to investigate the overprescribing of opioid painkillers, and to improve care for patients with persistent pain – without the use of long-term opioids.

This new research programme is led by Keele University’s Professor Christian Mallen, Director of the Institute for Primary Care and Health Sciences and NIHR Research Professor in General Practice, and Dr Julie Ashworth, Senior Lecturer and Consultant in Pain Medicine.

MP Steve Brine, Minister for Public Health and Primary Care, said:
“This exciting research comes at a time when we are tackling overprescribing head on to improve the care of those with long-term conditions and to reduce prescribing costs across the whole NHS. In understanding how we can better intervene at primary care level, we can prevent the complications that arise from long term opioid use which improves the quality of care for patients and reduces the burden on the NHS in the long-term. I would like to congratulate the research team at Keele University on receiving the grant and I look forward to following their progress.”